The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Elderly Stage III Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation

      The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R) is a national lung cancer registration that started in 2013 for patients treated with radical or curative intent radiotherapy. For elderly patients with locally advanced non-small cell lung cancer (NSCLC), real-world data is essential to be able to balance treatment toxicity and treatment outcome. The aim of this study is to analyze definitive chemoradiation (CRT) in elderly patients above 75 years of age with stage III NSCLC.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.